Medical Procedure News

RSS

ASTRO develops white paper on safe use of intensity modulated radiation therapy

As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.

15 Jul 2011

Wenzel Spine surpasses 26,000 implantation of VariLift System

Wenzel Spine, Inc., a medical device company focused on providing less invasive, stand-alone alternatives to traditional spinal fusion, today announced that it has successfully surpassed the 26,000th implantation of its Stand-Alone VariLift Expandable Interbody Fusion Device.

14 Jul 2011

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Short-term hormone therapy given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.

14 Jul 2011

Provision to eliminate lifetime benefit caps in medical insurance allows life-saving heart-lung transplant

The Affordable Care Act was signed into law March 23, 2010, with the aim of extending medical coverage to more Americans. The law has been a political football, and arguments continue to rage over whether it's good or bad for the country. This, however, is simply the story of how it affected one person.

14 Jul 2011

BIOTRONIK begins comparative study of ORSIRO stent with Abbott's XIENCE PRIME stent

BIOTRONIK announced today the start of an international study comparing the company's ORSIRO sirolimus-eluting coronary stent with Abbott Laboratory's XIENCE PRIME everolimus-eluting coronary stent. The first implantations in the study, called BIOFLOW-II, took place in Europe last week.

14 Jul 2011

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients to greater risk than other surgical options.

14 Jul 2011

Patients with brain cancer may benefit from stem cell therapy

Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.

14 Jul 2011

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the AdV HALT Trial (A Randomized, Placebo-Controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation [HSCT]).

14 Jul 2011

Wireless power system for ventricular assist devices holds promise

Mechanical pumps to give failing hearts a boost were originally developed as temporary measures for patients awaiting a heart transplant. But as the technology has improved, these ventricular assist devices commonly operate in patients for years, including in former vice-president Dick Cheney, whose implant this month celebrates its one-year anniversary.

13 Jul 2011

InfraReDx commences LipiScan IVUS System Phase 2 trial against heart attack

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).

13 Jul 2011

UCLA establishes new reconstructive transplantation program

In a major step into a new transplantation frontier, UCLA has established a first-of-its-kind program to restore functionality and enhance quality of life for people who have suffered severe trauma or other disfiguring injuries to the upper extremities, face or abdomen.

13 Jul 2011

Heart experts begin to test new device for treatment of blocked aortic valves

Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.

13 Jul 2011

Celprogen develops neuronal stem cells to treat Alzheimer's

Celprogen has developed neuronal stem cells that can be differentiated into neurons as an alternative for Cell based therapy for neurological diseases including Alzheimer's patients.

13 Jul 2011

Enrollment complete in Boston Scientific's Adapt Monorail Carotid Stent System trial

Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.

13 Jul 2011

FDA clears St. Jude Medical's Epiducer lead delivery system for neurostimulation

St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.

13 Jul 2011

New insights into how cancer cells can maintain resistance to chemotherapy

Researchers from the Royal College of Surgeons in Ireland (RCSI) have conducted a study which reveals new insights into how cancer cells can maintain a resistance to chemotherapy resulting in cancer relapse.

12 Jul 2011

African-Americans with glaucoma have higher oxygen levels than Caucasians

Measuring oxygen during eye surgery, investigators at Washington University School of Medicine in St. Louis have discovered a reason that may explain why African-Americans have a higher risk of glaucoma than Caucasians.

12 Jul 2011

Cardiologists still perform artery-opening procedure despite changes in guidelines

Despite changes in standard treatment practice guidelines issued by the American College of Cardiology, American Heart Association and the European Society of Cardiology several years ago, there has been no meaningful change in the nation's practice of opening completely blocked coronary arteries with balloons and stents in the days after a heart attack, according to a new study published in the July 11, 2011, issue of Archives of Internal Medicine.

12 Jul 2011

Hutchinson Center receives $20M NIH grant to eradicate HIV infection

Whether a stem cell transplant using an HIV-infected person's own genetically modified immune cells can become a cure for the disease is the focus of a new $20 million, five-year research grant award announced today by the National Institutes of Health to Fred Hutchinson Cancer Research Center.

12 Jul 2011

World's first double-leg transplant

Spanish surgeons, this Monday, performed the world's first double-leg transplant, giving an accident victim two new legs. Experts said it will be a month at least before the team will know if the procedure was a success. However if the legs are rejected that could happen immediately.

12 Jul 2011

Medical Procedure News

ASTRO develops white paper on safe use of intensity modulated radiation therapy

Wenzel Spine surpasses 26,000 implantation of VariLift System

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Provision to eliminate lifetime benefit caps in medical insurance allows life-saving heart-lung transplant

BIOTRONIK begins comparative study of ORSIRO stent with Abbott's XIENCE PRIME stent

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

Patients with brain cancer may benefit from stem cell therapy

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Wireless power system for ventricular assist devices holds promise

InfraReDx commences LipiScan IVUS System Phase 2 trial against heart attack

UCLA establishes new reconstructive transplantation program

Heart experts begin to test new device for treatment of blocked aortic valves

Celprogen develops neuronal stem cells to treat Alzheimer's

Enrollment complete in Boston Scientific's Adapt Monorail Carotid Stent System trial

FDA clears St. Jude Medical's Epiducer lead delivery system for neurostimulation

New insights into how cancer cells can maintain resistance to chemotherapy

African-Americans with glaucoma have higher oxygen levels than Caucasians

Cardiologists still perform artery-opening procedure despite changes in guidelines

Hutchinson Center receives $20M NIH grant to eradicate HIV infection

World's first double-leg transplant

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News